Skip to main content
Erschienen in: International Journal of Colorectal Disease 8/2019

05.07.2019 | Original Article

Common habitual behaviors and synchronous colorectal cancer risk: a retrospective case-control study

verfasst von: Yi-Hung Kuo, Hsin-Yuan Hung, Jeng-Fu You, Jy-Ming Chiang, Chih-Chien Chin

Erschienen in: International Journal of Colorectal Disease | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The association of habitual behaviors with the prevalence of synchronous colorectal cancer (sCRC) is unknown. Here, we investigated whether these behaviors, which are known risk factors for colorectal polyps, may be related to sCRC risk.

Methods

We enrolled 17,093 patients who underwent cancer treatment between January 1995 and December 2016 and examined the association of age, sex, familial history of hereditary colorectal cancer (CRC), and status of three common habitual behaviors (smoking and alcohol and coffee consumption) with the prevalence of sCRC.

Results

Of the enrolled patients, 960 (5.6%) patients had sCRC. The independent risk factors for sCRC prevalence included advanced age, male sex, hereditary CRC, smoking, and daily alcohol consumption of more than one bottle (> 600 mL). Contrary to these factors, daily coffee consumption of more than one cup seemed to provide a protection from sCRC. In the Kaplan-Meier test, the significantly worse 5-year overall survival (OS) was noted in smokers with stage 0–III CRC. The effect of alcohol consumption on 5-year OS was significant in stages II and III. Compared with those without daily coffee consumption, patients with daily coffee consumption had significantly higher 5-year OS in stages I (93.0% vs. 86.4%), II (87.1% vs. 77.2%), III (71.5% vs. 61.9%), and IV (18.0% vs. 13.0%).

Conclusions

sCRC prevalence was significantly associated with habitual behaviors. Patients with smoking or with daily alcohol consumption of one bottle had higher sCRC prevalence than did those without these habits. Coffee consumption could be a protective factor for lowering sCRC risk.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(suppl 8):S4–S66CrossRef Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(suppl 8):S4–S66CrossRef
2.
Zurück zum Zitat Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ (2002) Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2:37CrossRefPubMedPubMedCentral Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ (2002) Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2:37CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat World Health Organization (2014) International Agency for Research on Cancer, World cancer report 2014. pp 392–402: Stewart BW and Wild CP (eds) World Health Organization (2014) International Agency for Research on Cancer, World cancer report 2014. pp 392–402: Stewart BW and Wild CP (eds)
4.
Zurück zum Zitat Wang Y, Duan H, Yang H, Lin J (2015) A pooled analysis of alcohol intake and colorectal cancer. Int J Clin Exp Med 8:6878–6889PubMedPubMedCentral Wang Y, Duan H, Yang H, Lin J (2015) A pooled analysis of alcohol intake and colorectal cancer. Int J Clin Exp Med 8:6878–6889PubMedPubMedCentral
5.
Zurück zum Zitat Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, Berry TD (1997) Energy balance and colon cancer--beyond physical activity. Cancer Res 57:75–80PubMed Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, Berry TD (1997) Energy balance and colon cancer--beyond physical activity. Cancer Res 57:75–80PubMed
6.
Zurück zum Zitat Liang PS, Chen TY, Giovannucci E (2009) Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 124:2406–2415CrossRefPubMed Liang PS, Chen TY, Giovannucci E (2009) Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 124:2406–2415CrossRefPubMed
7.
Zurück zum Zitat Li G, Ma D, Zhang Y, Zheng W, Wang P (2013) Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutr 16:346–357CrossRefPubMed Li G, Ma D, Zhang Y, Zheng W, Wang P (2013) Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutr 16:346–357CrossRefPubMed
8.
Zurück zum Zitat Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S, JPHC Study Group Int (2007) Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. J Cancer 121:1312–1318 Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S, JPHC Study Group Int (2007) Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. J Cancer 121:1312–1318
9.
Zurück zum Zitat Schmit SL, Rennert HS, Rennert G, Gruber SB (2016) Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol Biomark Prev 25:634–639CrossRef Schmit SL, Rennert HS, Rennert G, Gruber SB (2016) Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol Biomark Prev 25:634–639CrossRef
10.
Zurück zum Zitat Thiels CA, Naik ND, Bergquist JR, Spindler BA, Habermann EB, Kelley SR, Wolff BG, Mathis KL (2016) Survival following synchronous colon cancer resection. J Surg Oncol 114:80–85CrossRefPubMed Thiels CA, Naik ND, Bergquist JR, Spindler BA, Habermann EB, Kelley SR, Wolff BG, Mathis KL (2016) Survival following synchronous colon cancer resection. J Surg Oncol 114:80–85CrossRefPubMed
11.
Zurück zum Zitat Latournerie M, Jooste V, Cottet V, Lepage C, Faivre J, Bouvier AM (2008) Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg 95:1528–1533CrossRefPubMed Latournerie M, Jooste V, Cottet V, Lepage C, Faivre J, Bouvier AM (2008) Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg 95:1528–1533CrossRefPubMed
13.
Zurück zum Zitat Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF (1978) Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299:448–451CrossRefPubMed Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF (1978) Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299:448–451CrossRefPubMed
14.
Zurück zum Zitat Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CC, Lin TC, Jiang JK, Yang SH, Wang HS, Chen PM (2000) Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer. Jpn J Clin Oncol 30:12–16CrossRefPubMed Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CC, Lin TC, Jiang JK, Yang SH, Wang HS, Chen PM (2000) Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer. Jpn J Clin Oncol 30:12–16CrossRefPubMed
15.
Zurück zum Zitat Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 116:1453–1456CrossRef Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 116:1453–1456CrossRef
16.
Zurück zum Zitat Lam AK, Chan SS, Leung M (2014) Synchronous colorectal cancer: clinical, pathological and molecular implications. World J Gastroenterol 20:6815–6820CrossRefPubMedPubMedCentral Lam AK, Chan SS, Leung M (2014) Synchronous colorectal cancer: clinical, pathological and molecular implications. World J Gastroenterol 20:6815–6820CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Reid ME, Marshall JR, Roe D, Lebowitz M, Alberts D, Battacharyya AK, Martinez ME (2003) Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas. Cancer Epidemiol Biomark Prev 12:1006–1011 Reid ME, Marshall JR, Roe D, Lebowitz M, Alberts D, Battacharyya AK, Martinez ME (2003) Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas. Cancer Epidemiol Biomark Prev 12:1006–1011
19.
Zurück zum Zitat Jacobson JS, Neugut AI, Murray T, Garbowski GC, Forde KA, Treat MR, Waye JD, Santos J, Ahsan H (1994) Cigarette smoking and other behavioral risk factors for recurrence of colorectal adenomatous polyps (New York City, NY, USA). Cancer Causes Control 5:215–220CrossRefPubMed Jacobson JS, Neugut AI, Murray T, Garbowski GC, Forde KA, Treat MR, Waye JD, Santos J, Ahsan H (1994) Cigarette smoking and other behavioral risk factors for recurrence of colorectal adenomatous polyps (New York City, NY, USA). Cancer Causes Control 5:215–220CrossRefPubMed
20.
21.
Zurück zum Zitat Erhardt JG, Kreichgauer HP, Meisner C, Bode JC, Bode C (2002) Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps--a case control study. Eur J Nutr 41:35–43CrossRefPubMed Erhardt JG, Kreichgauer HP, Meisner C, Bode JC, Bode C (2002) Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps--a case control study. Eur J Nutr 41:35–43CrossRefPubMed
22.
Zurück zum Zitat Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, Mahnke D, Gui J, Barry EL, Summers RW, McKeown-Eyssen G, Haile RW, Baron JA (2009) The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomark Prev 18:2310–2317CrossRef Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, Mahnke D, Gui J, Barry EL, Summers RW, McKeown-Eyssen G, Haile RW, Baron JA (2009) The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomark Prev 18:2310–2317CrossRef
24.
Zurück zum Zitat Figueiredo JC, Crockett SD, Snover DC, Morris CB, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Robertson DJ, Burke CA, Bresalier RS, Church JM, Church TR, Baron JA (2015) Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control 26:377–386CrossRef Figueiredo JC, Crockett SD, Snover DC, Morris CB, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Robertson DJ, Burke CA, Bresalier RS, Church JM, Church TR, Baron JA (2015) Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control 26:377–386CrossRef
25.
Zurück zum Zitat Nosho K, Kure S, Irahara N, Shima K, Baba Y, Spiegelman D, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S (2009) A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 137:1609–1620CrossRefPubMedPubMedCentral Nosho K, Kure S, Irahara N, Shima K, Baba Y, Spiegelman D, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S (2009) A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 137:1609–1620CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Drew DA, Nishihara R, Lochhead P, Kuchiba A, Qian ZR, Mima K, Nosho K, Wu K, Wang M, Giovannucci E, Fuchs CS, Chan AT, Ogino S (2017) A prospective study of smoking and risk of synchronous colorectal cancers. Am J Gastroenterol 112:493–501CrossRefPubMedPubMedCentral Drew DA, Nishihara R, Lochhead P, Kuchiba A, Qian ZR, Mima K, Nosho K, Wu K, Wang M, Giovannucci E, Fuchs CS, Chan AT, Ogino S (2017) A prospective study of smoking and risk of synchronous colorectal cancers. Am J Gastroenterol 112:493–501CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, Zheng W (2008) Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 167:1050–1058CrossRefPubMed Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, Zheng W (2008) Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 167:1050–1058CrossRefPubMed
28.
Zurück zum Zitat Lieberman DA, Prindiville S, Weiss DG, Willett W, VA Cooperative Study Group 380 (2003) Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 290:2959–2967CrossRefPubMed Lieberman DA, Prindiville S, Weiss DG, Willett W, VA Cooperative Study Group 380 (2003) Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 290:2959–2967CrossRefPubMed
29.
Zurück zum Zitat Cope GF, Wyatt JI, Pinder IF, Lee PN, Heatley RV, Kelleher J (1991) Alcohol consumption in patients with colorectal adenomatous polyps. Gut 32:70–72CrossRefPubMedPubMedCentral Cope GF, Wyatt JI, Pinder IF, Lee PN, Heatley RV, Kelleher J (1991) Alcohol consumption in patients with colorectal adenomatous polyps. Gut 32:70–72CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H (2000) Alcohol and cigarette smoking and the risk of colorectal adenomas. Dig Dis Sci 45:487–493CrossRefPubMed Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H (2000) Alcohol and cigarette smoking and the risk of colorectal adenomas. Dig Dis Sci 45:487–493CrossRefPubMed
31.
Zurück zum Zitat Tiemersma EW, Wark PA, Ocké MC, Bunschoten A, Otten MH, Kok FJ, Kampman E (2003) Alcohol consumption, alcohol dehydrogenase 3 polymorphism, and colorectal adenomas. Cancer Epidemiol Biomark Prev 12:419–425 Tiemersma EW, Wark PA, Ocké MC, Bunschoten A, Otten MH, Kok FJ, Kampman E (2003) Alcohol consumption, alcohol dehydrogenase 3 polymorphism, and colorectal adenomas. Cancer Epidemiol Biomark Prev 12:419–425
32.
Zurück zum Zitat Moskal A, Norat T, Ferrari P, Riboli E (2007) Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer 120:664–671CrossRefPubMed Moskal A, Norat T, Ferrari P, Riboli E (2007) Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer 120:664–671CrossRefPubMed
33.
Zurück zum Zitat Anderson JC, Alpern Z, Sethi G, Messina CR, Martin C, Hubbard PM, Grimson R, Ells PF, Shaw RD (2005) Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol 100:2049–2055CrossRefPubMed Anderson JC, Alpern Z, Sethi G, Messina CR, Martin C, Hubbard PM, Grimson R, Ells PF, Shaw RD (2005) Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol 100:2049–2055CrossRefPubMed
34.
Zurück zum Zitat Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, Matsushita S (1999) Cigarette smoking, alcohol use, and colorectal adenoma in Japanese men and women. Dis Colon Rectum 42:337–342CrossRefPubMed Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, Matsushita S (1999) Cigarette smoking, alcohol use, and colorectal adenoma in Japanese men and women. Dis Colon Rectum 42:337–342CrossRefPubMed
35.
Zurück zum Zitat Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO, Park SS, Yang S, Son HJ, Rhee PL, Kim JJ, Rhee JC, Choi YH (2007) Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomark Prev 16:1543–1546CrossRef Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO, Park SS, Yang S, Son HJ, Rhee PL, Kim JJ, Rhee JC, Choi YH (2007) Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomark Prev 16:1543–1546CrossRef
36.
Zurück zum Zitat Yamada K, Araki S, Tamura M, Sakai I, Takahashi Y, Kashihara H, Kono S (1997) Case-control study of colorectal carcinoma in situ and cancer in relation to cigarette smoking and alcohol use (Japan). Cancer Causes Control 8:780–785CrossRefPubMed Yamada K, Araki S, Tamura M, Sakai I, Takahashi Y, Kashihara H, Kono S (1997) Case-control study of colorectal carcinoma in situ and cancer in relation to cigarette smoking and alcohol use (Japan). Cancer Causes Control 8:780–785CrossRefPubMed
37.
Zurück zum Zitat Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD (2002) Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomark Prev 11:1012–1018 Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD (2002) Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomark Prev 11:1012–1018
38.
Zurück zum Zitat Kune GA, Bannerman S, Watson LF (1992) Attributable risk for diet, alcohol, and family history in the Melbourne Colorectal Cancer Study. Nutr Cancer 18:231–235CrossRefPubMed Kune GA, Bannerman S, Watson LF (1992) Attributable risk for diet, alcohol, and family history in the Melbourne Colorectal Cancer Study. Nutr Cancer 18:231–235CrossRefPubMed
39.
Zurück zum Zitat Seitz HK, Maurer B, Stickel F (2005) Alcohol consumption and cancer of the gastrointestinal tract. Dig Dis 23:297–303CrossRefPubMed Seitz HK, Maurer B, Stickel F (2005) Alcohol consumption and cancer of the gastrointestinal tract. Dig Dis 23:297–303CrossRefPubMed
40.
Zurück zum Zitat Gan Y, Wu J, Zhang S, Li L, Cao S, Mkandawire N, Ji K, Herath C, Gao C, Xu H, Zhou Y, Song X, Chen S, Chen Y, Yang T, Li J, Qiao Y, Hu S, Yin X, Lu Z (2017) Association of coffee consumption with risk of colorectal cancer: a meta-analysis of prospective cohort studies. Oncotarget 8:18699–18711PubMed Gan Y, Wu J, Zhang S, Li L, Cao S, Mkandawire N, Ji K, Herath C, Gao C, Xu H, Zhou Y, Song X, Chen S, Chen Y, Yang T, Li J, Qiao Y, Hu S, Yin X, Lu Z (2017) Association of coffee consumption with risk of colorectal cancer: a meta-analysis of prospective cohort studies. Oncotarget 8:18699–18711PubMed
41.
Zurück zum Zitat Galeone C, Turati F, La Vecchia C, Tavani A (2010) Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control 21:1949–1959CrossRefPubMed Galeone C, Turati F, La Vecchia C, Tavani A (2010) Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control 21:1949–1959CrossRefPubMed
42.
Zurück zum Zitat Kashino I, Akter S, Mizoue T, Sawada N, Kotemori A, Matsuo K, Oze I, Ito H, Naito M, Nakayama T, Kitamura Y, Tamakoshi A, Tsuji I, Sugawara Y, Inoue M, Nagata C, Sadakane A, Tanaka K, Tsugane S, Shimazu T, Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan (2018) Coffee drinking and colorectal cancer and its subsites: a pooled analysis of 8 cohort studies in Japan. Int J Cancer 143:307–316CrossRefPubMed Kashino I, Akter S, Mizoue T, Sawada N, Kotemori A, Matsuo K, Oze I, Ito H, Naito M, Nakayama T, Kitamura Y, Tamakoshi A, Tsuji I, Sugawara Y, Inoue M, Nagata C, Sadakane A, Tanaka K, Tsugane S, Shimazu T, Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan (2018) Coffee drinking and colorectal cancer and its subsites: a pooled analysis of 8 cohort studies in Japan. Int J Cancer 143:307–316CrossRefPubMed
43.
Zurück zum Zitat Setiawan VW, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, Henderson BE (2015) Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology 148:118–125CrossRefPubMed Setiawan VW, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, Henderson BE (2015) Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology 148:118–125CrossRefPubMed
44.
Zurück zum Zitat Sang LX, Chang B, Li XH, Jiang M (2013) Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol 13:34CrossRefPubMedPubMedCentral Sang LX, Chang B, Li XH, Jiang M (2013) Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol 13:34CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Akter S, Kashino I, Mizoue T, Matsuo K, Ito H, Wakai K, Nagata C, Nakayama T, Sadakane A, Tanaka K, Tamakoshi A, Sugawara Y, Sawada N, Inoue M, Tsugane S, Sasazuki S, for the Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan (2016) Coffee drinking and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population. Jpn J Clin Oncol 46:781–787CrossRefPubMed Akter S, Kashino I, Mizoue T, Matsuo K, Ito H, Wakai K, Nagata C, Nakayama T, Sadakane A, Tanaka K, Tamakoshi A, Sugawara Y, Sawada N, Inoue M, Tsugane S, Sasazuki S, for the Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan (2016) Coffee drinking and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population. Jpn J Clin Oncol 46:781–787CrossRefPubMed
46.
Zurück zum Zitat Cao S, Liu L, Yin X, Wang Y, Liu J, Lu Z (2014) Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies. Carcinogenesis 35:256–261CrossRefPubMed Cao S, Liu L, Yin X, Wang Y, Liu J, Lu Z (2014) Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies. Carcinogenesis 35:256–261CrossRefPubMed
47.
Zurück zum Zitat Araújo JR, Gonçalves P, Martel F (2011) Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res 31:77–87CrossRef Araújo JR, Gonçalves P, Martel F (2011) Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res 31:77–87CrossRef
48.
Zurück zum Zitat Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40:1155–1163CrossRefPubMed Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40:1155–1163CrossRefPubMed
Metadaten
Titel
Common habitual behaviors and synchronous colorectal cancer risk: a retrospective case-control study
verfasst von
Yi-Hung Kuo
Hsin-Yuan Hung
Jeng-Fu You
Jy-Ming Chiang
Chih-Chien Chin
Publikationsdatum
05.07.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 8/2019
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-019-03326-x

Weitere Artikel der Ausgabe 8/2019

International Journal of Colorectal Disease 8/2019 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.